Recent progress in understanding molecular mechanisms of cartilage degeneration during osteoarthritis

Annals of the New York Academy of Sciences

Volumn 1240, Issue 1, 2011, Pages 61-69

  Wang, Meina ^a   Shen, Jie ^a   Jin, Hongting ^a,b   Im, Hee Jeong ^c   Sandy, John ^c   Chen, Di ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adamts5; Articular cartilage; Growth factors; Mmp13; Osteoarthritis

Indexed keywords

AGGRECANASE 1; AGGRECANASE 2; BETA CATENIN; COLLAGEN; COLLAGENASE 3; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROTEIN PATCHED; PROTEOGLYCAN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; WNT PROTEIN; WNT3A PROTEIN;

APOPTOSIS; ARTICULAR CARTILAGE; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL PROLIFERATION; CELL SWELLING; DISEASE COURSE; EX VIVO STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; IN VIVO STUDY; INTRACELLULAR SIGNALING; MOLECULAR PATHOLOGY; NONHUMAN; OSTEOARTHRITIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 83755182740     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06258.x     Document Type: Review

References (80)

1. Meulenbelt, I., M. Kloppenburg, H.M. Kroon, et al. 2007. Clusters of biochemical markers are associated with radiographic subtypes of osteoarthritis (OA) in subject with familial OA at multiple sites. The GARP study. Osteoarthr. Cartilage 15: 379-385.
2. McGonagle, D., A.L. Tan, Carey, J. & M. Benjamin. 2010. The anatomical basis for a novel classification of osteoarthritis and allied disorders. J. Anat. 216: 279-291.
3. Plaas, A., J. Velasco, D.J. Gorski, et al. 2011. The relationship between fibrogenic TGFb1 signaling in the joint and cartilage degradation in post-injury osteoarthritis. Osteoarthr. Cartilage 19: 1081-90.
4. Bijlsma, J.W., F. Berenbaum & F.P. Lafeber. 2010. Osteoarthritis: an update with relevance for clinical practice. Lancet 377: 2115-2126.
5. Anderson, D.D., S. Chubinskaya, F. Guilak, et al. 2011. Post-traumatic osteoarthritis: improved understanding and opportunities for early intervention. J. Orthop. Res. 29: 802-809.
6. van den Berg, W.B. 2010. Osteoarthritis year 2010 in review: pathomechanisms. Osteoarthr. Cartilage 19: 338-341.
7. Schroeppel, J.P., J.D. Crist, H.C. Anderson & J. Wang. 2011. Molecular regulation of articular chondrocyte function and its significance in osteoarthritis. Histol. Histopathol. 26: 377-394.
8. Ehrlich, M.G., A.L. Armstrong, B.V. Treadwell & H.J. Mankin. 1986. Degradative enzyme systems in cartilage. Clin. Orthop. Relat. Res.213: 62-68.
9. Eyre, D.R., M.A. Weis & J.J. Wu. 2006. Articular cartilage collagen: an irreplaceable framework? Eur. Cell. Mater. 12: 57-63.
10. Wu, J.J., M.A. Weis, L.S. Kim & D.R. Eyre. 2011. Type III collagen, a fibril network modifier in articular cartilage. J. Biol. Chem. 285: 18537-18544.
11. Schumacher, B.L., J.A. Block, T.M. Schmid, et al. 1994. A novel proteoglycan synthesized and secreted by chondrocytes of the superficial zone of articular cartilage. Arch. Biochem. Biophys. 311: 144-152.
12. Wells, T., C. Davidson, M. Morgelin, J.L. Bird, et al. 2003. Age-related changes in the composition, the molecular stoichiometry and the stability of proteoglycan aggregates extracted from human articular cartilage. Biochem J. 370: 69-79.
13. Plaas, A.H., L.A. West, S. Wong-Palms & F.R. Nelson. 1998. Glycosaminoglycan sulfation in human osteoarthritis. Disease-related alterations at the non-reducing termini of chondroitin and dermatan sulfate. J. Biol. Chem. 273: 12642-12649.
14. Quinn, T.M., E.B. Hunziker & H.J. Hauselmann. 2005. Variation of cell and matrix morphologies in articular cartilage among locations in the adult human knee. Osteoarthr. Cartilage 13: 672-678.
15. Han, Y. & V. Lefebvre. 2008. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol. Cell. Biol. 28: 4999-5013.
16. Williams, R., I.M. Khan, K. Richardson, et al. 2011. Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. P.LoS. One. 5: e13246.
17. Elvenes, J., G. Knutsen, O. Johansen, et al. 2009. Development of a new method to harvest chondroprogenitor cells from underneath cartilage defects in the knees. J. Orthop. Sci. 14: 410-417.
18. Cawston, T.E. & D.A. Young. 2010. Proteinases involved in matrix turnover during cartilage and bone breakdown. Cell. Tissue. Res. 339: 221-235.
19. Sandy, J.D., P.J. Neame, R.E. Boynton & C.R. Flannery. 1991. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain. J. Biol. Chem. 266: 8683-8685.
20. Ilic, M.Z., C.J. Handley, H.C. Robinson & M.T. Mok. 1992. Mechanism of catabolism of aggrecan by articular cartilage. Arch. Biochem. Biophys. 294: 115-122.
21. Loulakis, P., A. Shrikhande, G. Davis & C.A. Maniglia. 1992. N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1-treated articular-cartilage cultures. Putative site(s) of enzymic cleavage. Biochem. J. 284: 589-593.
22. Brew, C.J., P.D. Clegg, R.P. Boot-Handford, et al. 2011. Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy. Ann. Rheum. Dis. 69: 234-240.
23. Aigner, T., K. Fundel, J. Saas, P.M. Gebhard, et al. 2006. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum. 54: 3533-3544.
24. Wei, T., N.H. Kulkarni, Q.Q. Zeng, et al. 2010. Analysis of early changes in the articular cartilage transcriptisome in the rat meniscal tear model of osteoarthritis: pathway comparisons with the rat anterior cruciate transection model and with human osteoarthritic cartilage. Osteoarthr. Cartilage 18: 992-1000.
25. Little, C.B., A. Barai, D. Burkhardt, et al. 2009. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum. 60: 3723-3733.
26. Li, J., W. Anemaet, M.A. Diaz, et al. 2011. Knockout of ADAMTS5 does not eliminate cartilage aggrecanase activity but abrogates joint fibrosis and promotes cartilage aggrecan deposition in murine osteoarthritis models. J. Orthop. Res. 4: 516-522.
27. Moodie, J.P., Stok, K.S., R. Muller, et al. 2011. Multimodal imaging demonstrates concomitant changes in bone and cartilage after destabilisation of the medial meniscus and increased joint laxity. Osteoarthr. Cartilage 19: 163-170.
28. Blaney Davidson, E.N., P.M. van der Kraan & W.B. van den Berg. 2007. TGF-β and osteoarthritis. Osteoarthr. Cartilage 15: 597-604.
29. Serra, R., M. Johnson, E.H. Filvaroff, et al. 1997. Expression of a truncated, kinase-defective TGF-β type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J. Cell Biol. 139: 541-552.
30. Yang, X., L. Chen, X. Xu, et al. 2001. TGF-β Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J. Cell Biol. 153: 35-46.
31. Zuscik, M.J., J.F. Baden, Q. Wu, et al. 2004. 5-Azacytidine alters TGF-β and BMP signaling and induces maturation in articular chondrocytes. J. Biol. Chem. 92: 316-331.
32. Wu, Q., M. Wang, M.J. Zuscik, et al. 2008. Regulation of embryonic endochondral ossification by Smurf2. J. Orthop. Res. 26: 704-712.
33. Wu, Q., K.O. Kim, E.R. Sampson, et al. 2008. Smurf2 induces an osteoarthritis-like phenotype and degrades phosphorylated Smad3 in transgenic mice. Arthritis Rheum. 58: 3132-3144.
34. Valdes, A.M., T.D. Spector, A. Tamm, et al. 2010. Genetic variation in the Smad3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum. 62: 2347-2352.
35. Yang, Y. 2003. Wnts and Wing: Wnt signaling in vertebrate limb development and musculoskeletal morphogenesis. Birth. Defects. Res. (PartC) 69: 305-317.
36. Zhu, M., D. Tang, Q. Wu, et al. 2009. Activation of β-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult β-catenin conditional activation mice. J. Bone. Miner. Res. 24: 12-21.
37. Clevers, H. 2006. Wnt/β-catenin signaling in development and disease. Cell 127: 469-80.
38. Day, T.F., X. Guo, L. Garrett-Beal & Y. Yang. 2005. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell. 8: 739-750.
39. Loughlin, J., B. Dowling, K. Chapman, et al. 2004. Functional variants within the secreted frizzled-related protein3 gene are associated with hip OA in females. Proc. Natl. Acad. Sci. USA. 101: 9757-9762.
40. Spector, T.D. & A.J. MacGregor. 2004. Risk factors for osteoarthritis: genetics [review]. Osteoarthr. Cartilage 12 (Suppl A): S39-S44.
41. Slagboom, P.E., B.T. Heijmans, M. Beekman, et al. 2000. Genetics of human aging: the search for genes contributing to human longevity and diseases of the old [review]. Ann. N.Y. Acad. Sci. 908: 50-63.
42. Loughlin, J., Z. Mustafa, A. Smith, et al. 2000. Linkage analysis of chromosome 2q in osteoarthritis. Rheumatology 39: 377-381.
43. Enomoto-Iwamoto, M., J. Kitagaki, E. Koyama, et al. 2002. The Wnt antagonist Frzb-1 regulates chondrocyte maturation and long bone development during limb skeletogenesis. Dev. Biol. 251: 142-156.
44. Tamamura, Y., T. Otani, N. Kanatani, et al. 2005. Developmental regulation of Wnt/β-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J. Biol. Chem. 280: 19185-19195.
45. Lories, R.J., J. Peeters, A. Bakker, et al. 2007. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum. 56: 4095-4103.
46. Blom, A.B., S.M. Brockbank, P.L. van Lent, et al. 2009. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1. Arthritis Rheum. 60: 501-512.
47. Chun, J.S., H. Oh, S. Yang & M. Park. 2008. Wnt signaling in cartilage development and degeneration. BMB. Rep. 41: 485-494.
48. Tian, H., S.L. McKnight & D.W. Russell. 1997. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes. Dev. 11: 72-82.
49. Patel, S.A. & M.C. Simon. 2008. Biology of hypoxia-inducible factor-2α in development and disease. Cell Death Differ. 15: 628-634.
50. Tian, H., R.E. Hammer, A.M. Matsumoto, et al. 1998. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes. Dev. 12: 3320-3324.
51. Saito, T., A. Fukai, A. Mabuchi, et al. 2010. Transcriptional regulation of endochondral ossification by HIF-2α during skeletal growth and osteoarthritis development. Nat. Med. 16: 678-686.
52. Yang, S., J. Kim, J.H. Ryu, et al. 2010. Hypoxia-inducible factor-2α is a catabolic regulator of osteoarthritic cartilage destruction. Nat. Med. 16: 687-693.
53. Lin, A.C., B.L. Seeto, J.M. Bartoszko, et al. 2009. Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat. Med. 15: 1421-1426.
54. Mak, K.K., M.H. Chen, T.F. Day, et al. 2006. Wnt/β-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation. Development 133: 3695-3707.
55. Vincenti, M.P. & C.E. Brinckerhoff. 2002. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 4: 157-164.
56. Shiomi, T., V. Lemaître, J. D'Armiento & Y. Okada. 2010. Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol. Int. 60: 477-496.
57. Knäuper, V., C. Lopez-Otin, B. Smith, G. Knight & G. Murphy. 1996. Biochemical characterization of human collagenase-3. J. Biol. Chem. 271: 1544-1550.
58. Reboul, P., J.P. Pelletier, G. Tardif, et al. 1996. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoarthritis. J. Clin. Invest. 97: 2011-2019.
59. Roach, H.I., N. Yamada, K.S. Cheung, et al. 2005. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 52: 3110-3124.
60. Stickens, D., D.J. Behonick, N. Ortega, et al. 2004. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 131: 5883-5895.
61. Inada, M., Y. Wang, M.H. Byrne, et al. 2004. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl. Acad. Sci. USA. 101: 17192-17197.
62. Neuhold, L.A., L. Killar, W. Zhao, et al. 2001. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J. Clin. Invest. 107: 35-44.
63. Gomis-Rüth, F.X. 2003. Structural aspects of the metzincin clan of metalloendopeptidases. Mol. Biotechnol. 24: 157-202.
64. Tang, B.L. 2001. ADAMTS: a novel family of extracellular matrix proteases. Int. J. Biochem. Cell. Biol. 33: 33-44.
65. Fosang, A.J. & C.B. Little. 2008. Drug insight: aggrecanases as therapeutic targets for osteoarthritis. Nat. Clin. Pract. Rheumatol. 4: 420-427.
66. Song, R.H., M.D. Tortorella, A.M. Malfait, et al. 2007. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum. 56: 575-585.
67. Tortorella, M.D., R.Q. Liu, T. Burn, et al. 2002. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol. 21: 499-511.
68. Kevorkian, L., D.A. Young, C. Darrah, et al. 2004. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum. 50: 131-141.
69. Glasson, S.S., R. Askew, B. Sheppard, et al. 2004. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum. 50: 2547-2558.
70. Glasson, S.S., R. Askew, B. Sheppard, et al. 2005. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434: 644-648.
71. Stanton, H., F.M. Rogerson, C. J. East, et al. 2005. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434: 648-652.
72. Echtermeyer, F., J. Bertrand, R. Dreier, et al. 2009. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat. Med. 15: 1072-1076.
73. Lohmander, L.S., L.M. Atley, T.A. Pietka & D.R. Eyre. 2003. The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum. 48: 3130-3139.
74. Poole, A.R., M. Ionescu, M.A. Fitzcharles & R.C. Billinghurst. 2004. The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases. J. Immunol. Methods 294: 145-153.
75. Charni, N., F. Juillet & P. Garnero. 2005. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum. 52: 1081-1090.
76. Dejica, V.M., J.S. Mort, S. Laverty, et al. 2008. Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage. Am. J. Pathol. 173: 161-169.
77. Sandy, J.D., C.R. Flannery, P.J. Neame & L. S. Lohmander. 1992. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J. Clin. Invest. 89: 1512-1516.
78. Lohmander, L.S., L. Dahlberg, D. Eyre, et al. 1998. Longitudinal and cross-sectional variability in markers of joint metabolism in patients with knee pain and articular cartilage abnormalities. Osteoarthr. Cartilage 6: 351-361.
79. Yang, S.F., Y.S. Hsieh, K.H. Lue, et al. 2008. Effects of nonsteroidal anti-inflammatory drugs on the expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans. Clin. Biochem. 41: 109-116.
80. Velasco, J., J. Li, L. Dipietro, et al. 2011. Adamts5 deletion blocks murine dermal repair through CD44-mediated aggrecan accumulation and modulation of transforming growth factor β1 (TGF-β) signaling. J. Biol. Chem. 286: 26016-26027.